Selin Esen

10PUBLICATIONS
77CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseaseNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 02, 2024
Pembrolizumab related perforated appendicitis.

Murat Kiracı, Selin Akturk Esen, Duriye Ozer Turkay

|Jul 20, 2024
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.

Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen

|Mar 29, 2024
Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?

Selin Aktürk Esen, Sefika Karabulut, Muge Buyukaksoy

|Mar 15, 2024
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms.

Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci

|Dec 29, 2023
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study.

Okan Oktar, Vakkas Korkmaz, Alp Tokalıoğlu

|Nov 30, 2023
Is the watch-and-wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?

Selin Akturk Esen, Dogan Uncu

Pageof 2

Frequent Collaborators

4 joint publications

Gokhan Ucar

3 joint publications

Ahmet Ozet

3 joint publications

Osman Sutcuoglu

3 joint publications

Ozan Yazıcı